GlassScriptPhysician profile
Luis Madera Marin
NPI 1689166795
$7,154.95
in general payments reported to CMS, 2019-2025
32 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $723 · 2020: $555 · 2021: $1,263 · 2022: $2,911 · 2023: $1,107 · 2024: $441 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,675 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $29.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,674.99 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $29.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $939.30 | 2019-2023 | |
| Amgen INC. | $760.25 | 2021-2023 | Repatha |
| Astrazeneca Pharmaceuticals LP | $724.16 | 2020-2023 | Lokelma |
| Boehringer Ingelheim Pharmaceuticals, INC. | $605.03 | 2020-2023 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $601.46 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $540.58 | 2019-2022 | |
| Dexcom, INC. | $299.18 | 2021-2023 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Novo Nordisk INC | $295.00 | 2021-2023 | Rybelsus, Ozempic |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $248.01 | 2019-2021 | |
| Pbg Puerto Rico LLC | $233.65 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $194.90 | 2021-2022 | |
| Corcept Therapeutics | $194.19 | 2021-2025 | Korlym |
| Abbott Laboratories | $165.93 | 2021-2023 | Freestyle Libre 2, Freestyle Libre 3 |
| Aurinia Pharma U.S., INC. | $124.25 | 2024 | Lupkynis |
| Mallinckrodt Hospital Products INC. | $124.25 | 2023 | Terlivaz |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $118.71 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $117.45 | 2024 | Jynarque |
| Medtronic, INC. | $107.92 | 2019-2021 | |
| Outset Medical INC | $100.82 | 2024 | |
| Mylan Specialty L.P. | $100.78 | 2019 | |
| Janssen Biotech, INC. | $98.27 | 2024 | Tremfya, Stelara |
| Eli Lilly Export S.A. Puerto Rico Branch | $92.99 | 2022-2023 | Mounjaro |
| Abbvie INC. | $69.72 | 2019-2023 | |
| Glaxosmithkline, LLC. | $68.57 | 2020 | |
| Bayer Puerto Rico INC. | $49.40 | 2023 | Kerendia |
| Novartis Pharmaceuticals Corporation | $46.43 | 2022 | |
| Chiesi USA, INC. | $34.90 | 2019-2021 | |
| Becton, Dickinson and Company | $29.00 | 2025 | Power-Trialysis |
| Takeda Pharmaceuticals U.S.A., INC. | $20.91 | 2023 | Livtencity |
| Radius Health, INC. | $17.21 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $16.05 | 2021 | |
| Pfizer Pharmaceuticals LLC | $15.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Madera Marin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.